Microbiology

  1. A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CL pro inhibitor PF-00835231 as a potential new treatment for COVID-19

    1. Maren de Vries
    2. Adil S Mohamed
    3. Rachel A Prescott
    4. Ana M Valero-Jimenez
    5. Ludovic Desvignes
    6. Rebecca O’Connor
    7. Claire Steppan
    8. Joseph C Devlin
    9. Ellie Ivanova
    10. Alberto Herrera
    11. Austin Schinlever
    12. Paige Loose
    13. Kelly Ruggles
    14. Sergei B Koralov
    15. Annaliesa S. Anderson
    16. Joseph Binder
    17. Meike Dittmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The Preclinical Inhibitor GS441524 in Combination with GC376 Efficaciously Inhibited the Proliferation of SARS-CoV-2 in the Mouse Respiratory Tract

    1. Yuejun Shi
    2. Lei Shuai
    3. Zhiyuan Wen
    4. Chong Wang
    5. Yuanyuan Yan
    6. Zhe Jiao
    7. Fenglin Guo
    8. Zhen F. Fu
    9. Huanchun Chen
    10. Zhigao Bu
    11. Guiqing Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Potent mouse monoclonal antibodies that block SARS-CoV-2 infection

    1. Youjia Guo
    2. Atsushi Kawaguchi
    3. Masaru Takeshita
    4. Takeshi Sekiya
    5. Mikako Hirohama
    6. Akio Yamashita
    7. the Keio Donner Project
    8. Haruhiko Siomi
    9. Kensaku Murano

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

    1. Conrad E.Z. Chan
    2. Shirley G.K. Seah
    3. De Hoe Chye
    4. Shane Massey
    5. Maricela Torres
    6. Angeline P.C. Lim
    7. Steven K.K. Wong
    8. Jacklyn J.Y. Neo
    9. Pui San Wong
    10. Jie Hui Lim
    11. Gary S.L. Loh
    12. Dong Ling Wang
    13. Jerome D. Boyd-Kirkup
    14. Siyu Guan
    15. Dipti Thakkar
    16. Guo Hui Teo
    17. Kiren Purushotorman
    18. Paul E. Hutchinson
    19. Barnaby E. Young
    20. David C. Lye
    21. Jenny G. Low
    22. Paul A. MacAry
    23. Hannes Hentze
    24. Venkateshan S. Prativadibhayankara
    25. Kantharaj Ethirajulu
    26. Damian O’Connell
    27. Jason Comer
    28. Chien-Te K. Tseng
    29. Alan D.T. Barrett
    30. Piers J. Ingram
    31. Trevor Brasel
    32. Brendon J. Hanson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Evolution and variation of 2019-novel coronavirus

    1. Chenglong Xiong
    2. Lufang Jiang
    3. Yue Chen
    4. Qingwu Jiang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant

    1. Enyia R. Anderson
    2. Grant L. Hughes
    3. Edward I. Patterson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating

    1. P Mlcochova
    2. A Chadha
    3. T Hesselhoj
    4. F Fraternali
    5. JJ Ramsden
    6. RK Gupta

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Nodosome inhibition as a novel broad-spectrum antiviral strategy against arboviruses and SARS-CoV-2

    1. Daniel Limonta
    2. Lovely Dyna-Dagman
    3. William Branton
    4. Tadashi Makio
    5. Richard W. Wozniak
    6. Christopher Power
    7. Tom C. Hobman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Extensive High-Order Complexes within SARS-CoV-2 Proteome Revealed by Compartmentalization-Aided Interaction Screening

    1. Weifan Xu
    2. Gaofeng Pei
    3. Hongrui Liu
    4. Jing Wang
    5. Pilong Li

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Broad-spectrum antiviral activity of 3D8, a nucleic acid-hydrolyzing single chain variable fragment (scFv), targeting SARS-CoV-2 and multiple coronaviruses in vitro

    1. Gunsup Lee
    2. Shailesh Budhathoki
    3. Geum-Young Lee
    4. Kwang-ji Oh
    5. Yeon Kyoung Ham
    6. Young Jun Kim
    7. Ye Rin Lim
    8. Phuong Thi Hoang
    9. Yongjun Lee
    10. Seok-Won Lim
    11. Jun-Mo Kim
    12. Seungchan Cho
    13. Tai-Hyun Kim
    14. Jin-Won Song
    15. Sukchan Lee
    16. Won-Keun Kim

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 166 of 252 Next